Invasive pneumococcal disease in the immunocompromised host

Microbial Drug Resistance

Volumn 3, Issue 3, 1997, Pages 215-232

  Janoff, Edward N ^a,b   Rubins, Jeffrey B ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ALCOHOL LIVER DISEASE; ARTICLE; COMPLEMENT DEFICIENCY; DIABETES MELLITUS; HIGH RISK POPULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNE DEFICIENCY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; MORTALITY; NEOPLASM; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; SICKLE CELL ANEMIA; SPLEEN DISEASE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; STREPTOCOCCUS PNEUMONIAE;

EID: 0030829370     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.1997.3.215     Document Type: Article

References (11)

1. Ahmed, F., M.C. Steinhoff, M.C. Rodriguez-Barradas, R.G. Hamilton, D.M. Musher, and K.E. Nelson. 1996. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: Results from a randomized trial. J. Infect. Dis. 173:83-90.
2. Ambrosino, D.M., G. Schiffman, B.C. Gotschlich, P.H. Schur, G.A. Rosenbcrg, G.G. DeLange, E. vanLoghem, and G.R. Siber. 1985. Correlation between G2M(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J. Clin. Invest. 75:1935-1942.
3. Amdahl, B.D., J.B. Rubins, C.L. Daley, C.F. Gilks, P.C. Hopewell, and E.N. Janoff. 1995. Impaired natural immunity to pneumolysin during human immunodeficiency virus infection in the United States and Africa. Amer. J. Resp. Crit. Care Med. 152:2000-2004.
4. Amman, A.J., G. Schiffman, D. Abrams, P. Volberding, J. Ziegler, and M. Conant. 1984. B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA 251:1447-1449.
5. Andiman, W.A., J. Mezger, and E. Shapiro. 1994. Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1. J. Pediatr. 124:846-852.
6. Arpadi, S., and S.B. Hauger. 1992. Causes of fever and predictors of pneumococcal bacteremia in HIV-infected children. Pediatr. AIDS and HIV: Fetus to adolescent. 4:187-192.
7. Arpadi, S.M., S. Back, J. O'Brien, and E.N. Janoff. 1994. Antibodies to pneumococcal capsular polysaccharides in HIV-infected children given polyvalent pneumococcal vaccine. J. Pediatr. 125:77-79.
8. Austrian, R., and J. Gold. 1964. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med. 60:759-776.
9. Avanzini, M.A., A.M. Carra, R. Maccario, M. Zecca, P. Pignatti, M. Marconi, P. Comoli, F. Bonetti, P. DeStefano, and F. Locatelli. 1995. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J. Clin. Immunol. 15:137-144.
10. Baker, P.J., D.F. Amsbaugh, P.W. Stashak, G. Caldes, and B. Prescott. 1981. Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells. Rev. Infect. Dis. 3:332-341.
11. Barat, L.M., J.E. Gunn, K.A. Sieger, C.J. Perkins, and D.E. Craven. 1996. Causes of fever in patients infected with human immunodeficiency virus who were admitted to Boston City Hospital. Clin. Infect. Dis. 23:320-328.